Clinical Trials Browser

NCT07431216 2026-02-24

A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression

Phase 1/2 Not yet recruiting

68 enrolled

CNS

Glioblastoma

NCT03068910 2025-08-05

CRM008

Phase EARLY_PHASE1 Recruiting

32 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT04723862 2025-08-05

CBS010

Phase EARLY_PHASE1 Recruiting

32 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT05933265 2025-03-06

Study of LP-184 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

175 enrolled

Breast

Neoplasm Metastasis, Neoplasms, Triple Negative Breast Neoplasms

NCT01422759 2023-10-27

Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess

Phase NA Unknown

20 enrolled

Other

Obesity, Polycystic Ovary Syndrome

NCT04075149 2023-10-27

CBS009

Phase EARLY_PHASE1 Unknown

24 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

NCT06005259 2023-08-22

SPIROTOX

Phase 4 Unknown

264 enrolled

Heart Failure, Neoplasms, Cardiotoxicity

NCT03867682 2023-08-04

Venetoclax and Lintuzumab-Ac225 in AML Patients

Phase 1/2 Unknown

38 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01867294 2020-01-09

Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab

Phase 2 Completed

19 enrolled 9 charts

Other neoplasm

Advanced Malignant Neoplasm

NCT02689843 2019-11-12

AntiPCO

Phase EARLY_PHASE1 Completed

90 enrolled

Inflammation, Polycystic Ovary Syndrome

NCT02531412 2017-01-04

SPIROCAN

Phase 2/3 Unknown

24 enrolled

Genitourinary

Neoplasms, Critical Illness, Acute Kidney Injury

NCT01526616 2012-02-06

Spironolactone Plus Metformin in Polycystic Ovary Syndrome

Phase NA Completed

56 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome

NCT00842140 2010-07-22

Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) Women

Phase NA Completed

75 enrolled

Cardiovascular Diseases, Polycystic Ovary Syndrome

NCT00004311 2005-06-24

Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome

Phase 2 Completed

Acanthosis Nigricans, Endocrine System Diseases, Polycystic Ovary Syndrome, Skin Diseases, Rare Diseases